Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Predicting 15-year prostate cancer specific mortality after radical prostatectomy.
Eggener SE, Scardino PT, Walsh PC, Han M, Partin AW, Trock BJ, Feng Z, Wood DP, Eastham JA, Yossepowitch O, Rabah DM, Kattan MW, Yu C, Klein EA, Stephenson AJ.
J Urol. 2011 Mar;185(3):869-75. doi: 10.1016/j.juro.2010.10.057. Epub 2011 Jan 15.
Similar articles
Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy.
Brockman JA, Alanee S, Vickers AJ, Scardino PT, Wood DP, Kibel AS, Lin DW, Bianco FJ Jr, Rabah DM, Klein EA, Ciezki JP, Gao T, Kattan MW, Stephenson AJ.
Eur Urol. 2015 Jun;67(6):1160-1167. doi: 10.1016/j.eururo.2014.09.019. Epub 2014 Oct 6.
Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era.
Kibel AS, Ciezki JP, Klein EA, Reddy CA, Lubahn JD, Haslag-Minoff J, Deasy JO, Michalski JM, Kallogjeri D, Piccirillo JF, Rabah DM, Yu C, Kattan MW, Stephenson AJ.
J Urol. 2012 Apr;187(4):1259-65. doi: 10.1016/j.juro.2011.11.084. Epub 2012 Feb 14.
Are biochemical recurrence outcomes similar after radical prostatectomy and radiation therapy? Analysis of prostate cancer-specific mortality by nomogram-predicted risks of biochemical recurrence.
Lee BH, Kibel AS, Ciezki JP, Klein EA, Reddy CA, Yu C, Kattan MW, Stephenson AJ.
Eur Urol. 2015 Feb;67(2):204-9. doi: 10.1016/j.eururo.2014.09.017. Epub 2014 Oct 5.
Recovery of erectile function after salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy.
Masterson TA, Stephenson AJ, Scardino PT, Eastham JA.
Urology. 2005 Sep;66(3):623-6.
Comparison of observed biochemical recurrence-free survival in patients with low PSA values undergoing radical prostatectomy and predictions of preoperative nomogram.
Berglund RK, Stephenson AJ, Cronin AM, Vickers AJ, Eastham JA, Klein EA, Guillonneau BD.
Urology. 2009 May;73(5):1098-103. doi: 10.1016/j.urology.2008.07.052. Epub 2009 Mar 17.
Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate cancer after radiation therapy.
Stephenson AJ, Scardino PT, Bianco FJ Jr, DiBlasio CJ, Fearn PA, Eastham JA.
J Urol. 2004 Dec;172(6 Pt 1):2239-43.
Location, extent and number of positive surgical margins do not improve accuracy of predicting prostate cancer recurrence after radical prostatectomy.
Stephenson AJ, Wood DP, Kattan MW, Klein EA, Scardino PT, Eastham JA, Carver BS.
J Urol. 2009 Oct;182(4):1357-63. doi: 10.1016/j.juro.2009.06.046. Epub 2009 Aug 14.
Clinicians versus nomogram: predicting future technetium-99m bone scan positivity in patients with rising prostate-specific antigen after radical prostatectomy for prostate cancer.
Kattan MW, Yu C, Stephenson AJ, Sartor O, Tombal B.
Urology. 2013 May;81(5):956-61. doi: 10.1016/j.urology.2012.12.010. Epub 2013 Jan 30.
A genomic classifier improves prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy without adjuvant therapy.
Klein EA, Yousefi K, Haddad Z, Choeurng V, Buerki C, Stephenson AJ, Li J, Kattan MW, Magi-Galluzzi C, Davicioni E.
Eur Urol. 2015 Apr;67(4):778-86. doi: 10.1016/j.eururo.2014.10.036. Epub 2014 Nov 12.
Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.
Stephenson AJ, Scardino PT, Eastham JA, Bianco FJ Jr, Dotan ZA, DiBlasio CJ, Reuther A, Klein EA, Kattan MW.
J Clin Oncol. 2005 Oct 1;23(28):7005-12.
Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.
Stephenson AJ, Scardino PT, Eastham JA, Bianco FJ Jr, Dotan ZA, Fearn PA, Kattan MW.
J Natl Cancer Inst. 2006 May 17;98(10):715-7. Erratum in: J Natl Cancer Inst. 2012 Mar 7;104(5):423.
Decipher Genomic Classifier Measured on Prostate Biopsy Predicts Metastasis Risk.
Klein EA, Haddad Z, Yousefi K, Lam LL, Wang Q, Choeurng V, Palmer-Aronsten B, Buerki C, Davicioni E, Li J, Kattan MW, Stephenson AJ, Magi-Galluzzi C.
Urology. 2016 Apr;90:148-52. doi: 10.1016/j.urology.2016.01.012. Epub 2016 Jan 22.
Validation of pretreatment nomograms for predicting indolent prostate cancer: efficacy in contemporary urological practice.
Dong F, Kattan MW, Steyerberg EW, Jones JS, Stephenson AJ, Schröder FH, Klein EA.
J Urol. 2008 Jul;180(1):150-4; discussion 154. doi: 10.1016/j.juro.2008.03.053. Epub 2008 May 15.
Mortality after prostate cancer treatment with radical prostatectomy, external-beam radiation therapy, or brachytherapy in men without comorbidity.
Nepple KG, Stephenson AJ, Kallogjeri D, Michalski J, Grubb RL 3rd, Strope SA, Haslag-Minoff J, Piccirillo JF, Ciezki JP, Klein EA, Reddy CA, Yu C, Kattan MW, Kibel AS.
Eur Urol. 2013 Sep;64(3):372-8. doi: 10.1016/j.eururo.2013.03.005. Epub 2013 Mar 13.
Natural history of biochemical recurrence after radical prostatectomy: risk assessment for secondary therapy.
Simmons MN, Stephenson AJ, Klein EA.
Eur Urol. 2007 May;51(5):1175-84. Epub 2007 Jan 12. Review.
The Single-parameter, Structure-based IsoPSA Assay Demonstrates Improved Diagnostic Accuracy for Detection of Any Prostate Cancer and High-grade Prostate Cancer Compared to a Concentration-based Assay of Total Prostate-specific Antigen: A Preliminary Report.
Klein EA, Chait A, Hafron JM, Kernen KM, Manickam K, Stephenson AJ, Wagner M, Zhu H, Kestranek A, Zaslavsky B, Stovsky M.
Eur Urol. 2017 Dec;72(6):942-949. doi: 10.1016/j.eururo.2017.03.025. Epub 2017 Apr 7.
Optimal definition of biochemical recurrence after radical prostatectomy depends on pathologic risk factors: identifying candidates for early salvage therapy.
Mir MC, Li J, Klink JC, Kattan MW, Klein EA, Stephenson AJ.
Eur Urol. 2014 Aug;66(2):204-10. doi: 10.1016/j.eururo.2013.08.022. Epub 2013 Aug 20.
Avoiding androgen deprivation therapy in men with high-risk prostate cancer: the role of radical prostatectomy as initial treatment.
Miocinovic R, Berglund RK, Stephenson AJ, Jones JS, Fergany A, Kaouk J, Klein EA.
Urology. 2011 Apr;77(4):946-50. doi: 10.1016/j.urology.2010.11.057.
Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition.
Stephenson AJ, Kattan MW, Eastham JA, Dotan ZA, Bianco FJ Jr, Lilja H, Scardino PT.
J Clin Oncol. 2006 Aug 20;24(24):3973-8.
Filters: Manage Filters